Aperio Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $562K | Buy |
27,036
+2,199
| +9% | +$45.7K | ﹤0.01% | 1909 |
|
|
2020
Q3 | $538K | Buy |
24,837
+3,571
| +17% | +$77.4K | ﹤0.01% | 1774 |
|
|
2020
Q2 | $501K | Buy |
21,266
+2,593
| +14% | +$61.1K | ﹤0.01% | 1783 |
|
|
2020
Q1 | $220K | Buy |
18,673
+2,727
| +17% | +$32.1K | ﹤0.01% | 2060 |
|
|
2019
Q4 | $169K | Sell |
15,946
-7,306
| -31% | -$77.4K | ﹤0.01% | 2219 |
|
|
2019
Q3 | $265K | Buy |
23,252
+6,981
| +43% | +$79.6K | ﹤0.01% | 2068 |
|
|
2019
Q2 | $183K | Buy |
+16,271
| New | +$183K | ﹤0.01% | 2211 |
|